Am J Otolaryngol Head Neck Surg | Volume 2, Issue 4 | Case Report | Open Access

Plasmacytoma an Infrequent and Particular Tumor of Nasal Cavity: A New Case Report

Khemir A1*, Adouni O1, Chiba D1, Goucha A1, Kamoun S1, Bettaieb I1, Gritli S2 and Gamoudi A1

1Departments of Pathological Anatomy and Cytology, Tunisia University of El Manar, Tunisia
2Department of Otorhinolaryngology and Cervicofacial Surgery, Tunisia University of El Manar, Tunisia

*Correspondance to: Khemir A 

Fulltext PDF

Abstract

We report a new case of extra-medullary solitary plasmacytoma of the nasal cavity in order to emphasize this rare tumor with a predilection for sinuses and nasal cavity levels and to expose its diagnostic and therapeutic features. It was a 60-years-old woman who consulted for a left-sided nasal cavity mass associated with an epistaxis. The clinical examination revealed a swelling of the left nasal region. CT-scan showed a mass completely filling the maxillary sinus, ethmoidal cells, frontal sinus and sphenoidal sinus. The cervico-facial MRI showed a soft tissue mass completely filling the left maxillary sinus enlarging the ostium, the osteomatous intersection and the left nasal cavity, associated with a frontal and ethmoidal sinusal reaction of the left anterior sinus. Histopathologically, it was a monoclonal plasma cells proliferation. Skeletal imaging confirmed the absence of bone localization. Results of serum electrophoresis and urine tests were negative for myeloma component or Bence-Jones protein. The diagnosis of extramedullary plasmacytoma of the nasal cavity was therefore retained. Extramedullary plasmacytoma of the nasal cavity is rare and should be considered in the differential diagnosis of nasal cavity masses especially in young age group.

Keywords:

Nasal; Plasmacytoma; Solitary; Extra-medullary

Citation:

Khemir A, Adouni O, Chiba D, Goucha A, Kamoun S, Bettaieb I, et al. Plasmacytoma an Infrequent and Particular Tumor of Nasal Cavity: A New Case Report. Am J Otolaryngol Head Neck Surg. 2019;2(4):1046.

Subscribe to Our Newsletter